- Home
- AUUD vs SONN Comparison
AUUD vs SONN Comparison
Compare AUUD & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- SONN
- Stock Information
- Founded
- AUUD 2012
- SONN N/A
- Country
- AUUD United States
- SONN United States
- Employees
- AUUD N/A
- SONN N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- SONN Health Care
- Exchange
- AUUD Nasdaq
- SONN Nasdaq
- Market Cap
- AUUD 3.1M
- SONN 2.5M
- IPO Year
- AUUD 2021
- SONN N/A
- Fundamental
- Price
- AUUD $0.49
- SONN $1.54
- Analyst Decision
- AUUD
- SONN Strong Buy
- Analyst Count
- AUUD 0
- SONN 2
- Target Price
- AUUD N/A
- SONN $38.00
- AVG Volume (30 Days)
- AUUD 1.2M
- SONN 267.1K
- Earning Date
- AUUD 11-07-2024
- SONN 02-12-2025
- Dividend Yield
- AUUD N/A
- SONN N/A
- EPS Growth
- AUUD N/A
- SONN N/A
- EPS
- AUUD N/A
- SONN N/A
- Revenue
- AUUD N/A
- SONN $18,626.00
- Revenue This Year
- AUUD N/A
- SONN N/A
- Revenue Next Year
- AUUD N/A
- SONN N/A
- P/E Ratio
- AUUD N/A
- SONN N/A
- Revenue Growth
- AUUD N/A
- SONN N/A
- 52 Week Low
- AUUD $0.43
- SONN $1.41
- 52 Week High
- AUUD $11.75
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- AUUD 43.62
- SONN 36.95
- Support Level
- AUUD $0.46
- SONN $1.46
- Resistance Level
- AUUD $0.61
- SONN $2.52
- Average True Range (ATR)
- AUUD 0.05
- SONN 0.18
- MACD
- AUUD -0.00
- SONN 0.06
- Stochastic Oscillator
- AUUD 19.74
- SONN 9.26
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products include Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.